Achieve Life Sciences (ACHV) Equity Ratio (2016 - 2026)
Achieve Life Sciences (ACHV) has disclosed Equity Ratio for 17 consecutive years, with 0.32 as the latest value for Q1 2026.
- Quarterly Equity Ratio fell 14.15% to 0.32 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.32 through Mar 2026, down 14.15% year-over-year, with the annual reading at 0.51 for FY2025, 4.82% down from the prior year.
- Equity Ratio for Q1 2026 was 0.32 at Achieve Life Sciences, down from 0.51 in the prior quarter.
- The five-year high for Equity Ratio was 0.71 in Q2 2025, with the low at 0.07 in Q4 2023.
- Average Equity Ratio over 5 years is 0.4, with a median of 0.39 recorded in 2022.
- The sharpest move saw Equity Ratio crashed 126.98% in 2023, then surged 3215.58% in 2024.
- Achieve Life Sciences' Equity Ratio stood at 0.28 in 2022, then crashed by 126.98% to 0.07 in 2023, then surged by 823.69% to 0.54 in 2024, then fell by 4.82% to 0.51 in 2025, then plummeted by 37.36% to 0.32 in 2026.
- Per Business Quant, the three most recent readings for ACHV's Equity Ratio are 0.32 (Q1 2026), 0.51 (Q4 2025), and 0.65 (Q3 2025).